Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control
Open Access
- 25 January 2018
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 18 (1) , 1-6
Abstract
Peripheral neuropathy is one most common, limiting and invalidating neurological symptom in subjects with hepatitis C virus and mixed cryoglobulinemia. Notably, the medical therapy proposed to eradicate HCV, can frequently exacerbate the painful neuropathy. Therefore, neuropathy therapies are insufficient and inadequate, and comprise immunosuppressive drugs, such as steroid or cyclosporine, intravenous immunoglobulin or plasma exchange. These have shown variable success in case reports, with a presumably temporary effect, but with major side effects. We assessed the effects of oxcarbazepine treatment in 67 cases of cryoglobulinemia related neuropathy, who did not respond to either steroid or Gabapentin, or Pregabalin. Oxcarbazepine was chosen based on the promising preliminary results. Patients treated with Oxcarbazepine showed a rapid, discrete and persistent relief of polyneuropathic signs, without consistent side effects, and with a limited interaction with concomitant drugs. These data favor the use of oxcarbazepine as a useful tool in the management of neuropathic pain associated with Hepatitis–C cryoglobulin neuropathy.Keywords
Funding Information
- FIRB (U12GPFIRB11)
This publication has 45 references indexed in Scilit:
- The cryoglobulinaemiasThe Lancet, 2012
- Treatment of hepatitis C-virus-related glomerulonephritisKidney International, 2006
- Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in ratsNeuropharmacology, 2005
- PEGylated interferon alfa‐2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitisArthritis & Rheumatism, 2005
- Oxcarbazepine (Trileptal®) monotherapy dramatically improves quality of life in two patients with postherpetic neuralgia refractory to carbamazepine and gabapentinJournal of Pain and Symptom Management, 2004
- Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groupsHepatology, 2003
- Interferon‐α and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitisArthritis & Rheumatism, 2002
- Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathyMuscle & Nerve, 2002
- Severe exacerbation of hepatitis C–associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature reviewMuscle & Nerve, 2002
- The short-form McGill pain questionnairePain, 1987